The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Gene Therapy

• Publication date

  1997-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3300438PMID 9231074
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Vivo Replication-Deficient Adenovirus Vector-Mediated Transduction of the Cytosine Deaminase Gene Sensitizes Glioma Cells to 5-Fluorocytosine

  1996cited by this paper
• Preservation of the bystander cytocidal effect of irradiated herpes simplex virus thymidine kinase (HSV-tk) modified tumor cells

  1996cited by this paper
• Gap junctions play a role in the 'bystander effect' of the herpes simplex virus thymidine kinase/ganciclovir system in vitro.

  1996cited by this paper
• Tumor cells expressing the herpes simplex virus-thymidine kinase gene in the treatment of Walker 256 meningeal neoplasia in rats.

  1996cited by this paper
• X-linked dominant Charcot-Marie-Tooth disease and other potential gap-junction diseases of the nervous system.

  1995cited by this paper
• Selectivity of connexin-specific gap junctions does not correlate with channel conductance.

  1995cited by this paper
• The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro.

  1995cited by this paper
• A more potent bystander cytocidal effect elicited by tumor cells expressing the herpes simplex virus-thymidine kinase gene than by fibroblast virus-producer cells in vitro.

  1995cited by this paper
• Functional analysis of selective interactions among rodent connexins.

  1995cited by this paper
• Properties of gap junction channels formed of connexin 45 endogenously expressed in human hepatoma (SKHep1) cells.

  1995cited by this paper
• Exogenous Expression of Connexins for Physiological Characterization of Channel Properties: Comparison of Methods and Results

  1995cited by this paper
• Cancer gene therapy: A bystander effect using the gap junctional pathway

  1994cited by this paper
• Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection.

  1994cited by this paper
• Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.

  1994cited by this paper
• Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation?

  1994cited by this paper
• Bystander tumoricidal effect in the treatment of experimental brain tumors.

  1994cited by this paper
• Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene.

  1994cited by this paper
• Expression of gap junction proteins Cx26, Cx31.1, Cx37, and Cx43 in developing and mature rat epidermis

  1994cited by this paper
• The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats.

  1994cited by this paper
• Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors.

  1994cited by this paper
• Specificity of gap junction communication among human mammary cells and connexin transfectants in culture

  1993cited by this paper
• Molecular cloning and functional expression of human connexin37, an endothelial cell gap junction protein.

  1993cited by this paper
• In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.

  1993cited by this paper
• Regression of established macroscopic liver metastases after in situ transduction of a suicide gene.

  1993cited by this paper
• In Vitro Evidence That Metabolic Cooperation Is Responsible for the Bystander Effect Observed with HSV tk Retroviral Gene Therapy

  1993cited by this paper
• Thymidine kinase-mediated killing of rat brain tumors.

  1993cited by this paper
• The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

  1993cited by this paper
• Four novel members of the connexin family of gap junction proteins. Molecular cloning, expression, and chromosome mapping.

  1992cited by this paper
• In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors.

  1992cited by this paper
• Gap junctions: new tools, new answers, new questions.

  1991cited by this paper
• Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene.

  1991cited by this paper
• Gap junctional intercellular communication and carcinogenesis.

  1990cited by this paper
• Molecular characterization and functional expression of the human cardiac gap junction channel

  1990cited by this paper
• Expression of gap junction channels in communication-incompetent cells after stable transfection with cDNA encoding connexin 32.

  1990cited by this paper
• Connexin family of gap junction proteins

  1990cited by this paper
• Development of in vivo models for studies of brain metastasis

  1988cited by this paper
• Site-directed mutagenesis of a nucleotide-binding domain in HSV-1 thymidine kinase: effects on catalytic activity.

  1988cited by this paper
• Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat.

  1986cited by this paper
• Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy.

  1986cited by this paper

• Modified hTERT promoters-driven purine nucleoside phosphorylase-gene therapy in association with chemo- and targeted therapy in the context of ovarian cancer

  2025cites this paper
• Nicotine does not affect stem cell properties requisite for suicide gene therapy against glioma

  2020cites this paper
• Connexins in cancer: bridging the gap to the clinic

  2019cites this paper
• Involvement of gap junctions in propylthiouracil-induced cytotoxicity in BRL-3A cells.

  2019cites this paper
• The Microvascular Gap Junction Channel: A Route to Deliver MicroRNAs for Neurological Disease Treatment

  2017cites this paper
• Gap junctions and cancer: communicating for 50 years

  2016cites this paper
• Genetics: Transcribing for the enemy

  2016cites this paper
• Gefitinib enhances oxaliplatin-induced apoptosis mediated by Src and PKC-modulated gap junction function.

  2016cites this paper
• Gap junction composed of connexin43 modulates 5‑fluorouracil, oxaliplatin and irinotecan resistance on colorectal cancers.

  2016cites this paper
• Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT

  2015cites this paper
• Gap junctions and Bystander Effects: Good Samaritans and executioners.

  2013cites this paper
• Targeting Intercellular Communication in Cancer Gene Therapy

  2013cites this paper
• Gap junctions propagate opposite effects in normal and tumor testicular cells in response to cisplatin.

  2012cites this paper
• Bystander effect in glioma suicide gene therapy using bone marrow stromal cells.

  2012cites this paper
• Connexins: key mediators of endocrine function.

  2011cites this paper
• E-cadherin contributes to the bystander effect of TK/GCV suicide therapy and enhances its antitumoral activity in pancreatic cancer models

  2011cites this paper
• ATP Release Via Connexin Hemichannels Controls Intercellular Propagation of Ca2+ Waves in Corneal Endothelial Cells

  2010cites this paper
• HDAC inhibitor valproic acid enhances tumor cell kill in adenovirus‐HSVtk mediated suicide gene therapy in HNSCC xenograft mouse model

  2010cites this paper
• Passage through vertebrate gap junctions of 17/18kDa molecules is primarily dependent upon molecular configuration.

  2010cites this paper
• Connexin modulators and their potential targets under the magnifying glass.

  2010cites this paper
• Extracellular ATP and Adenosine as Regulators of Endothelial Cell Function

  2010cites this paper
• Engineering novel suicide enzymes for improved cancer gene therapy

  2009cites this paper
• Gene and Virotherapy Against Osteosarcoma

  2009cites this paper
• The role of gap junctions in cellular migration

  2009cites this paper
• Pannexins, distant relatives of the connexin family with specific cellular functions?

  2009influential citation
• NT-polyplex: a new tool for therapeutic gene delivery to neuroblastoma tumors

  2009cites this paper
• Fusion Enzymes Containing HSV-1 Thymidine Kinase Mutants and Guanylate Kinase Enhance Prodrug Sensitivity In Vitro and In Vivo

  2009cites this paper
• The Role of DNA Damage and Repair in Ganciclovir-mediated Cytotoxicity.

  2008cites this paper
• Hurdles and Improvements in Therapeutic Gene Transfer for Cancer

  2007cites this paper
• A novel G418 conjugate results in targeted selection of genetically protected hepatocytes without bystander toxicity.

  2007cites this paper
• Suicide genes for cancer therapy.

  2007cites this paper
• Enhancement of HSV-TK / GCV suicide gene therapy of cancer

  2006cites this paper
• Connexin Over-Expression Differentially Suppresses Glioma Growth and Contributes to the Bystander Effect Following HSV-Thymidine Kinase Gene Therapy

  2006cites this paper
• Gap junctional intercellular communication in bovine corneal endothelial cells.

  2006cites this paper
• Gene therapy for carcinoma of the breast

  2006cites this paper
• Expression of Connexins in Chromaffin Cells of Normal Human Adrenals and in Benign and Malignant Pheochromocytomas

  2006cites this paper
• Adenovirus-Mediated HSV-tk Gene Therapy for Malignant Glioma: Clinical Experience

  2006cites this paper
• Gap junctions remain open during cytochrome c-induced cell death: relationship of conductance to ‘bystander’ cell killing

  2006cites this paper
• Identification of factors important for the success of suicide gene therapy after a comparative study of Varicella zoster and Herpes simplex viral thymidine kinases efficacy on breast cancer cells.

  2005cites this paper
• Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas.

  2005cites this paper
• Direct evidence for the absence of intercellular trafficking of VP22 fused to GFP or to the herpes simplex virus thymidine kinase

  2005cites this paper
• Gene transfer to glial tumors using herpes simplex virus.

  2004cites this paper
• Targeting gene therapy for prostate cancer.

  2004cites this paper
• Methods to improve efficacy in suicide gene therapy approaches: targeting prodrug-activating enzymes carboxypeptidase G2 and nitroreductase to different subcellular compartments.

  2004cites this paper
• Cytogenetic detection of a trans-species bystander effect: induction of sister chromatid exchanges in murine 3T3 cells by ganciclovir metabolized in HSV thymidine kinase gene-transfected Chinese hamster ovary cells.

  2004cites this paper
• Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.

  2004cites this paper
• Bovine Herpesvirus Tegument Protein VP22 Enhances Thymidine Kinase/Ganciclovir Suicide Gene Therapy for Neuroblastomas Compared to Herpes Simplex Virus VP22

  2004cites this paper
• Gene Therapy for the Treatment of Cancer

  2004cites this paper
• CHAPTER 15 – Cell–Cell Communication: An Overview Emphasizing Gap Junctions

  2004cites this paper
• Suicide gene therapy with Herpes simplex virus thymidine kinase and ganciclovir is enhanced with connexins to improve gap junctions and bystander effects.

  2003cites this paper
• Gap Junctions Mediate Bystander Cell Death in Developing Retina

  2003cites this paper
• Tumor suppressor genes of bladder cancer and potential for gene therapy.

  2003cites this paper
• Oncolytic viral therapy for human ovarian cancer using a novel replication-competent herpes simplex virus type I mutant in a mouse model.

  2003cites this paper
• Nonviral Approaches for Cancer Gene Therapy

  2003cites this paper
• The combination of HSV-tk and endostatin gene therapy eradicates orthotopic human renal cell carcinomas in nude mice

  2002cites this paper
• Oncolytic Herpes Simplex Virus (G207) Therapy

  2002cites this paper
• Purified herpes simplex virus thymidine kinase retroviral particles:

  2002cites this paper
• Antiviral agents alter ability of HSV-2 to disrupt gap junctional intercellular communication between mammalian cells in vitro.

  2002cites this paper
• Connexin 43–mediated bystander effect in two rat glioma cell models

  2002cites this paper
• Cytosine deaminase and thymidine kinase gene therapy in a Dunning rat prostate tumour model: absence of bystander effects and characterisation of 5-fluorocytosine metabolism with 19F-NMR spectroscopy

  2002cites this paper
• Intratumoral activation of cyclophosphamide by retroviral transfer of the cytochrome P450 2B1 in a pancreatic tumor model. Combination with the HSVtk/GCV system

  2002cites this paper
• Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice.

  2002cites this paper
• Antitumor effects on human melanoma xenografts of an amplicon vector transducing the herpes thymidine kinase gene followed by ganciclovir

  2002cites this paper
• Ganciclovir prodrug therapy is effective in a murine xenotransplant model of human lung cancer.

  2002cites this paper
• Connexin 26 Gene Therapy of Human Bladder Cancer: Induction of Growth Suppression, Apoptosis, and Synergy with Cisplatin

  2001cites this paper
• Efficacy of the bystander effect in the herpes simplex virus thymidine kinase-mediated gene therapy is influenced by the expression of connexin43 in the target cells

  2001cites this paper
• Investigation of connexin gene expression patterns by in situ hybridization techniques.

  2001cites this paper
• Retrovirus‐mediated transfer of the herpes simplex virus thymidine kinase and connexin26 genes in pancreatic cells results in variable efficiency on the bystander killing: Implications for gene therapy

  2001cites this paper
• Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery

  2001cites this paper
• Bystander effects of cancer cell lines transduced with the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster and synergistic enhancement by hydroxyurea.

  2001cites this paper
• Stimulation of intercellular communication of poor‐communicating cells by gap‐junction‐competent cells enhances the HSV‐TK/GCV bystander effect in vitro

  2001cites this paper
• HSV-2 disrupts gap junctional intercellular communication between mammalian cells in vitro.

  2001cites this paper
• Connexin 43-enhanced suicide gene therapy using herpesviral vectors.

  2000cites this paper
• Inducible expression of herpes simplex virus thymidine kinase increases sensitivity to ganciclovir but does not enhance bystander effect in breast cancer cells

  2000cites this paper
• Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors

  2000cites this paper
• Alpha1 connexin 43 gap junctions are decreased in human adrenocortical tumors.

  2000cites this paper
• The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy

  2000cites this paper
• Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication.

  2000cites this paper
• Combined suicide and granulocyte–macrophage colony-stimulating factor gene therapy induces complete tumor regression and generates antitumor immunity

  2000cites this paper
• Gap junctions: the "kiss of death" and the "kiss of life".

  2000cites this paper
• Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model

  2000cites this paper
• Regressions of Established Breast Carcinoma Xenografts by Carboxypeptidase G2 Suicide Gene Therapy and the Prodrug CMDA Are Due to a Bystander Effect

  2000cites this paper
• Cell population dynamics (apoptosis, mitosis, and cell-cell communication) during disruption of homeostasis.

  2000cites this paper
• Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir

  2000cites this paper
• Gap junction function

  2000cites this paper
• Expression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954

  2000cites this paper
• GAP junctions during neoplastic transformation

  2000cites this paper
• Tumor-selective gene transduction and cell killing with an oncotropic autonomous parvovirus-based vector

  2000cites this paper
• Prodrug activation enzymes in cancer gene therapy

  2000cites this paper
• Gap Junctions in Glia

  1999cites this paper
• Catch VP22: the hitch-hiker’s ride to gene therapy?

  1999cites this paper
• Tentative novel mechanism of the bystander effect in glioma gene therapy with HSV-TK/GCV system.

  1999cites this paper
• Molecular aspects of ovarian cancer. Is gene therapy the solution?

  1999cites this paper
• Ganciclovir-mediated in vivo elimination of myeloid leukemic cells expressing the HSVtk gene induces HSVtk loss variants

  1999cites this paper
• Gap junctions in glia. Types, roles, and plasticity.

  1999cites this paper
• Connexins are expressed in primary brain tumors and enhance the bystander effect in gene therapy.

  1999cites this paper
• Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22

  1999cites this paper
• Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene

  1999cites this paper
• Cells producing recombinant retrovirus with thymidine kinase gene from Herpes simplex virus suitable for human cancer gene therapy.

  1999cites this paper
• Impact of Preexisting and Induced Humoral and Cellular Immune Responses in an Adenovirus-Based Gene Therapy Phase I Clinical Trial for Localized Mesothelioma

  1998cites this paper